Project/Area Number |
13480198
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Functional biochemistry
|
Research Institution | HOKKAIDO UNIVERSITY |
Principal Investigator |
IGARASHI Yasuyuki Hokkaido Univ., Grad. School of Pharm., Prof., 大学院・薬学研究科, 教授 (70091965)
|
Co-Investigator(Kenkyū-buntansha) |
YATOMI Yutaka University of Tokyo, Fac. of Med., Asso. Prof., 大学院・医学系研究科, 助教授 (60200523)
MITSUTAKE Susumu Hokkaido Univ., Grad. School of Pharm., Inst., 大学院・薬学研究科, 助手 (10344475)
KIHARA Akio Hokkaido Univ., Grad. School of Pharm., Inst., 大学院・薬学研究科, 助手 (50333620)
和田 淳 北海道大学, 大学院・薬学研究科, 助手 (00301953)
|
Project Period (FY) |
2001 – 2003
|
Project Status |
Completed (Fiscal Year 2003)
|
Budget Amount *help |
¥15,000,000 (Direct Cost: ¥15,000,000)
Fiscal Year 2003: ¥4,400,000 (Direct Cost: ¥4,400,000)
Fiscal Year 2002: ¥4,400,000 (Direct Cost: ¥4,400,000)
Fiscal Year 2001: ¥6,200,000 (Direct Cost: ¥6,200,000)
|
Keywords | bioactive lipids / sphingosine1-phosphate / Edg Receptors / lysophosphatidic acid / ABC transporter / sphingosine kinase / alycolipids / lipid signaling / リゾボスファチジン酸 / GPCR |
Research Abstract |
The receptors for serum-borne lysophospholipid mediators such as sphingosine1-phosphate (S1P) and lysophosphatidic acid (LPA) was identified in these several years and their physiological and pathophysiological roles have been strongly concerned. These bioactive lipids were observed to be released from activated platelets, but the detailed mechanism of their production, secretion and degradation have not been thoroughly studied. Therefore, in this three years Japan-USA research project, we have tried to clarify the molecular mechanism of production, secretion, and degradation of these bioactive lysolipids in the strong collaboration between Japanese and American groups. Through the collaboration we tried and found the following results. (1) Blood S1P is derived mainly from stimulated platelets and LPA is partially released from stimulated platelets but mostly produced in the blood by phospholipases which are released from activated platelets with the aids of lysophospholipase D. (2) We partially purified the responsible phospholipases which produce the lysophospholipids from the blood phospholipids. (3) The involvement of ABC transporter in S1P releasing from platelets was found but we could not determine the specific ABC transporter involved. (4) We identified for the first time a sphingolipid transporter RSB 1, a ATP-dependent new type of six transmembrane transporter, which can exclude the over-loaded DHS and PHS from yeast cells (5) We determined the molecular mechanism of ligand-receptor interaction utilizing computational model of Edg-6 (S1P6)/S1P interaction. By these collaboration studies we enriched our knowledge how the metabolism and functions of the blood-borne bioactive lysolipids such as LPA and S1P are regulated, indicating the importance of the regulations of these lysolipids in blood vessel biology and pathology.
|